3D-bioprinted cardiac tissues and their potential for disease modeling
- PMID: 38250545
- PMCID: PMC10798787
- DOI: 10.2217/3dp-2022-0023
3D-bioprinted cardiac tissues and their potential for disease modeling
Abstract
Heart diseases cause over 17.9 million total deaths globally, making them the leading source of mortality. The aim of this review is to describe the characteristic mechanical, chemical and cellular properties of human cardiac tissue and how these properties can be mimicked in 3D bioprinted tissues. Furthermore, the authors review how current healthy cardiac models are being 3D bioprinted using extrusion-, laser- and inkjet-based printers. The review then discusses the pathologies of cardiac diseases and how bioprinting could be used to fabricate models to study these diseases and potentially find new drug targets for such diseases. Finally, the challenges and future directions of cardiac disease modeling using 3D bioprinting techniques are explored.
Keywords: bioprinting; cardiac tissues; cardiomyocytes; disease modelling; review; stem cells.
Figures
References
-
- Cardiovascular Diseases (CVDs). WHO, Geneva, Switzerland: (2021). www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
-
- Heart Diseases in Canada. Public Health Agency of Canada, Ottawa, Canada: (2021). www.canada.ca/en/public-health/services/publications/diseases-conditions...
-
- Heart Disease Facts. Centers for Disease Control and Prevention, MD, USA: (2022). www.cdc.gov/heartdisease/facts.htm
-
- Milani-Nejad N, Janssen PML. Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharm. Ther 141(3), 235–249 (2014). - PMC - PubMed
-
• This article provides interesting insights into the advantages and disadvantages of small and large animal models, which is important for this review, since it provides insights into the need for other types of models such as bioprinted models.
Grants and funding
LinkOut - more resources
Full Text Sources